 Avantax Advisory Services Inc. purchased a new position in shares of Horizon Therapeutics Public Limited NASDAQ:HZNP during the third quarter, according to its most recent filing with the Securities and Exchange Commission SEC. The fund purchased 10,603 shares of the biopharmaceutical companys stock, valued at approximately 824,000. Other institutional investors have also recently modified their ... 